CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
-
Oct 20 2015
-
-
Source: JAMA. 314(15):1581-1587
[PDF-408.00 KB]
Details:
-
Alternative Title:JAMA
-
Personal Author:
-
Description:IMPORTANCE
The Advisory Committee on Immunization Practices (ACIP) recommends the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each pregnancy, regardless of prior immunization status. However, safety data on repeated Tdap vaccination in pregnancy is lacking.
OBJECTIVE
To determine whether receipt of Tdap vaccine during pregnancy administered in close intervals from prior tetanus-containing vaccinations is associated with acute adverse events in mothers and adverse birth outcomes in neonates.
DESIGN, SETTING, AND PARTICIPANTS
A retrospective cohort study in 29 155 pregnant women aged 14 through 49 years from January 1,2007, through November 15,2013, using data from 7 Vaccine Safety Datalink sites in California, Colorado, Minnesota, Oregon, Washington, and Wisconsin.
EXPOSURES
Women who received Tdap in pregnancy following a prior tetanus-containing vaccine less than 2 years before, 2 to 5 years before, and more than 5 years before.
MAIN OUTCOMES AND MEASURES
Acute adverse events (fever, allergy, and local reactions) and adverse birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated. Women who were vaccinated with Tdap in pregnancy and had a prior tetanus-containing vaccine more than 5 years before served as controls.
RESULTS
There were no statistically significant differences in rates of medically attended acute adverse events or adverse birth outcomes related to timing since prior tetanus-containing vaccination. Time Since Prior Tetanus-Containing Vaccination, yOutcome <2 2–5 >5 (Control)Local reactions, rate/10 000 women4.27.011.2 Adjusted risk ratio (95% CI)0.49 (0.11–2.20)0.77 (0.31–1.95)1 [Reference] P value.35.59Preterm delivery, %6.66.46.8 Adjusted risk ratio (95% CI)1.15 (0.98–1.34)1.06 (0.94–1.19)1 [Reference] P value.08.33Small for gestational age, %9.08.79.1 Adjusted risk ratio (95% CI)0.99 (0.87–1.13)0.96 (0.87–1.06)1 [Reference] P value.88.45
CONCLUSIONS AND RELEVANCE
Among women who received Tdap vaccination during pregnancy, there was no increased risk of acute adverse events or adverse birth outcomes for those who had been previously vaccinated less than 2 years before or 2 to 5 years before compared with those who had been vaccinated more than 5 years before. These findings suggest that relatively recent receipt of a prior tetanus-containing vaccination does not increase risk after Tdap vaccination in pregnancy.
-
Subjects:
-
Source:
-
Pubmed ID:26501534
-
Pubmed Central ID:PMC6586223
-
Document Type:
-
Funding:
-
Volume:314
-
Issue:15
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
